title: Comparison of open three-field and minimally-invasive esophagectomy for esophageal cancer.
abstract: The aim was to compare the early outcomes between thoracoscopic and laparoscopic esophagectomy (TLE) and open three-field esophagectomy for esophageal cancer. We retrospectively analyzed clinical data from 96 patients with esophageal cancer who underwent TLE, and 78 patients who underwent open three-field esophagectomy from March 2008 to September 2010. All the operations were successful. There was no significant difference between TLE and open three-field esophagectomy with regard to the number of lymph nodes procured (17.75±5.56 vs. 18.03±6.20, P>0.05), complications (32.3% vs. 46.2%, P>0.05), and operative mortality (2.1% vs. 3.8%, P>0.05). However, hospital stay was significantly shorter in the TLE group than the open esophagectomy group (12.64±8.82 vs. 17.53±6.40 days, P<0.01), and the TLE group had significantly less blood loss (346.68±41.13 vs. 519.26±47.74 ml, P<0.01). This showed that TLE for esophageal cancer offers results as good as or better than those with open three-field esophagectomy.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
authors.forename: Yongshan
authors.initials: Y
authors.lastname: Gao
authors.forename: Yun
authors.initials: Y
authors.lastname: Wang
authors.forename: Longqi
authors.initials: L
authors.lastname: Chen
authors.forename: Yongfan
authors.initials: Y
authors.lastname: Zhao
mesh_terms: D000368:Aged; D016063:Blood Loss, Surgical; D016009:Chi-Square Distribution; D002681:China; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016629:Esophagectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000401:mortality; D007902:Length of Stay; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D013906:Thoracoscopy / Q000009:adverse effects / Q000401:mortality; D013997:Time Factors; D016896:Treatment Outcome